Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
2023年12月4日 - 10:00PM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (QB) (USOTC:PRVCF)
過去 株価チャート
から 5 2024 まで 6 2024
PreveCeutical Medical (QB) (USOTC:PRVCF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about PreveCeutical Medical Inc (QB) (その他OTC): 0 recent articles
その他のPreveCeutical Medical Inc (QB)ニュース記事